
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15831885
[patent_doc_number] => 20200131224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => Methods for Synthesis of Radionuclide Complex
[patent_app_type] => utility
[patent_app_number] => 16/393103
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393103 | Methods for Synthesis of Radionuclide Complex | Apr 23, 2019 | Abandoned |
Array
(
[id] => 14682455
[patent_doc_number] => 20190240342
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => ORGANIC ANION TRANSPORTING PEPTIDE-BASED CANCER IMAGING AND THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/390384
[patent_app_country] => US
[patent_app_date] => 2019-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8395
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/390384 | ORGANIC ANION TRANSPORTING PEPTIDE-BASED CANCER IMAGING AND THERAPY | Apr 21, 2019 | Abandoned |
Array
(
[id] => 17384019
[patent_doc_number] => 20220031871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/048072
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048072
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048072 | ANTIBODIES FOR CHELATED RADIONUCLIDES AND CLEARING AGENTS | Apr 15, 2019 | Pending |
Array
(
[id] => 16853586
[patent_doc_number] => 20210154331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => CYCLOPHANES FOR LIVE-CELL IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/047748
[patent_app_country] => US
[patent_app_date] => 2019-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047748
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047748 | Cyclophanes for live-cell imaging | Apr 15, 2019 | Issued |
Array
(
[id] => 19089770
[patent_doc_number] => 11951189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Targeting compounds and methods for their production
[patent_app_type] => utility
[patent_app_number] => 17/046053
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6102
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046053
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046053 | Targeting compounds and methods for their production | Apr 10, 2019 | Issued |
Array
(
[id] => 16581548
[patent_doc_number] => 20210015950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => FORMULATIONS AND KITS FOR RADIOTHERAPY AND DIAGNOSTIC IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/042772
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042772 | Formulations and kits for radiotherapy and diagnostic imaging | Apr 10, 2019 | Issued |
Array
(
[id] => 14649557
[patent_doc_number] => 20190231907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Metal Complexes with Bisphophonate or Pyrophosphate Useful as Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 16/373803
[patent_app_country] => US
[patent_app_date] => 2019-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373803
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373803 | Metal complexes with bisphophonate or pyrophosphate useful as imaging agents | Apr 2, 2019 | Issued |
Array
(
[id] => 14621491
[patent_doc_number] => 20190224113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
[patent_app_type] => utility
[patent_app_number] => 16/371440
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371440
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/371440 | Method for preventing nasolacrimal duct obstruction | Mar 31, 2019 | Issued |
Array
(
[id] => 16612229
[patent_doc_number] => 20210030882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => USE OF BIS-IMINOBIOTIN COMPOUND FOR DRUG DELIVERY PURPOSES
[patent_app_type] => utility
[patent_app_number] => 17/042534
[patent_app_country] => US
[patent_app_date] => 2019-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/042534 | USE OF BIS-IMINOBIOTIN COMPOUND FOR DRUG DELIVERY PURPOSES | Mar 28, 2019 | Abandoned |
Array
(
[id] => 16627542
[patent_doc_number] => 20210046195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => FORMULATION AND METHOD OF PREPARATION
[patent_app_type] => utility
[patent_app_number] => 17/041759
[patent_app_country] => US
[patent_app_date] => 2019-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041759
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041759 | FORMULATION AND METHOD OF PREPARATION | Mar 25, 2019 | Abandoned |
Array
(
[id] => 15604337
[patent_doc_number] => 10583209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Hyperpolarized 1-13C-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for MR
[patent_app_type] => utility
[patent_app_number] => 16/363193
[patent_app_country] => US
[patent_app_date] => 2019-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 8628
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16363193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/363193 | Hyperpolarized 1-13C-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for MR | Mar 24, 2019 | Issued |
Array
(
[id] => 17549395
[patent_doc_number] => 20220120736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES
[patent_app_type] => utility
[patent_app_number] => 17/040967
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 110709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040967
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040967 | METHODS AND ASSAYS FOR MODULATING GENE TRANSCRIPTION BY MODULATING CONDENSATES | Mar 21, 2019 | Pending |
Array
(
[id] => 16778316
[patent_doc_number] => 20210115394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => SCAFFOLD
[patent_app_type] => utility
[patent_app_number] => 16/981843
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981843
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981843 | SCAFFOLD | Mar 18, 2019 | Abandoned |
Array
(
[id] => 16581547
[patent_doc_number] => 20210015949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => 177Lu-DOTA-HYNIC-iPSMA AS A THERAPEUTIC RADIOPHARMACEUTICAL TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN
[patent_app_type] => utility
[patent_app_number] => 16/980252
[patent_app_country] => US
[patent_app_date] => 2019-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16980252
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/980252 | None | Mar 6, 2019 | Issued |
Array
(
[id] => 16466836
[patent_doc_number] => 20200368373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => OPTICAL IMAGING AGENTS TARGETING INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/968272
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9299
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/968272 | OPTICAL IMAGING AGENTS TARGETING INFLAMMATION | Feb 20, 2019 | Abandoned |
Array
(
[id] => 16539477
[patent_doc_number] => 20200405890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => POSITRON EMISSION TOMOGRAPHY IMAGING OF ACTIVATABLE BINDING POLYPEPTIDES AND RELATED COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/971671
[patent_app_country] => US
[patent_app_date] => 2019-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -110
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971671 | POSITRON EMISSION TOMOGRAPHY IMAGING OF ACTIVATABLE BINDING POLYPEPTIDES AND RELATED COMPOSITIONS THEREOF | Feb 20, 2019 | Abandoned |
Array
(
[id] => 16748910
[patent_doc_number] => 20210100919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/970155
[patent_app_country] => US
[patent_app_date] => 2019-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970155
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/970155 | Heptamethine cyanines for use as fluorescent markers of the biliary and renal systems | Feb 13, 2019 | Issued |
Array
(
[id] => 14744005
[patent_doc_number] => 20190255176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => SYSTEM FOR THE DIRECT PRODUCTION OF THERAPEUTIC YTTRIUM-90 FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/274592
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274592 | System for the direct production of therapeutic yttrium-90 for cancer treatment | Feb 12, 2019 | Issued |
Array
(
[id] => 17719158
[patent_doc_number] => 20220211877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => COMPOUND FOR INTRAOPERATIVE MOLECULAR BIOIMAGING, METHOD OF MAKING THE SAME, USE THEREOF IN INTRAOPERATIVE MOLECULAR BIOIMAGING AND SURGICAL METHOD COMPRISING INTRAOPERATIVE MOLECULAR BIOIMAGING
[patent_app_type] => utility
[patent_app_number] => 16/967624
[patent_app_country] => US
[patent_app_date] => 2019-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8959
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16967624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/967624 | COMPOUND FOR INTRAOPERATIVE MOLECULAR BIOIMAGING, METHOD OF MAKING THE SAME, USE THEREOF IN INTRAOPERATIVE MOLECULAR BIOIMAGING AND SURGICAL METHOD COMPRISING INTRAOPERATIVE MOLECULAR BIOIMAGING | Feb 5, 2019 | Abandoned |
Array
(
[id] => 16320237
[patent_doc_number] => 10780184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-22
[patent_title] => Fluorescent solid lipid nanoparticles composition and preparation thereof
[patent_app_type] => utility
[patent_app_number] => 16/263769
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 13250
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263769
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/263769 | Fluorescent solid lipid nanoparticles composition and preparation thereof | Jan 30, 2019 | Issued |